Search

Your search keyword '"Oben, Jude"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Oben, Jude" Remove constraint Author: "Oben, Jude"
321 results on '"Oben, Jude"'

Search Results

1. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis

2. Obesity and NAFLD

3. The British Association for the Study of the Liver commitment to equality, diversity, and inclusivity

7. Impact of Yaq-001, a non-absorbable, engineered carbon bead of controlled porosity in rodent models of cirrhosis and acute on chronic liver failure

8. Contributors

10. Yaq-001, a non-absorbable, engineered carbon beads of controlled porosity impacts on gut dysbiosis, gut permeability, organ function and reduces mortality in rodent models of cirrhosis and ACLF

15. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

16. A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease

28. Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease

30. Advancing the global public health agenda for NAFLD: a consensus statement

36. Pediatric Non-Alcoholic Fatty Liver Disease is Affected by Genetic Variants Involved in Lifespan/Healthspan

37. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study

39. Additional file 1 of Obesity-induced nucleosome release predicts poor cardio-metabolic health

40. MOESM1 of Obesity-induced nucleosome release predicts poor cardio-metabolic health

41. TOP-042 - Yaq-001, a non-absorbable, engineered carbon beads of controlled porosity impacts on gut dysbiosis, gut permeability, organ function and reduces mortality in rodent models of cirrhosis and ACLF

45. The impact of virologic resistance and adherence on treatment failure in a cohort of hepatitis C virus (HCV) infected patients treated with telaprevir (TVR) and boceprevir (BOC): 1089

49. A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet

50. GDF11 induces mild hepatic fibrosis independent of metabolic health

Catalog

Books, media, physical & digital resources